Cart
sales@molnova.com
AG-1557 hydrochloride
CAS No. ——
AG-1557 hydrochloride ( —— )
Catalog No. M19479 CAS No. ——
AG-1557 is an inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase (pIC50: 8.194).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 49 | Get Quote |
|
| 10MG | 78 | Get Quote |
|
| 25MG | 155 | Get Quote |
|
| 50MG | 286 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAG-1557 hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionAG-1557 is an inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase (pIC50: 8.194).
-
DescriptionAG-1557 is an inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase (pIC50: 8.194).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetEGFR
-
RecptorhERG|EGFR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight443.66
-
Molecular FormulaC16H15ClIN3O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESCl.COc1cc2ncnc(Nc3cccc(I)c3)c2cc1OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Joshi A. Gadhwal M. and Joshi U.J. Indentification of potential novel EGFR inhibitors using a combination of pharmacophore and docking methods Int. J. Pharm. Pharmaceut. Sci. 7(6) (2015).
molnova catalog
related products
-
Epertinib
Epertinib (S-222611) is a novel potent, orally active, reversible EGFR and HER2 inhibitor with IC50 of 1.48, 7.15 and 2.49 nM for EGFR, HER2 and HER4, respectively.
-
EGFR-IN-11
EGFR-IN-11 is a selective inhibitor of EGFR-tyrosine kinase and induces cell apoptosis. EGFR-IN-11 inhibits triple mutant EGFRL858R/T790M/C797S with an IC50 of 18 nM and arrests cell cycle at G0/G1.
-
Peiminine
Peiminine is an effective inhibitor for lung inflammation and pulmonary fibrosis in a rat model of bleomycin-induced lung injury.
